Peptable

Comparison

Setmelanotide vs SS-31

Function

While Setmelanotide is approved for chronic weight management in patients with POMC, PCSK1, LEPR deficiencies and Bardet–Biedl syndrome by reducing hunger and promoting weight loss92, SS-31 improves mitochondrial bioenergetics, reduces oxidative stress, and shows protective effects in models of ischemia-reperfusion, neurodegeneration, and other mitochondrial disorders4637137.

Mechanism

While Setmelanotide works as a potent synthetic melanocortin-4 receptor (MC4R) agonist derived from a POMC/α-MSH–related sequence that restores downstream MC4R signaling in genetic obesity syndromes3192100, SS-31 is a mitochondria-targeted tetrapeptide, d-Arg-dimethylTyr-Lys-Phe-NH2, that selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure, improving electron transport, and reducing ROS production4637137143.

Receptor

Setmelanotide

Melanocortin-4 receptor (MC4R) 3192100

SS-31

Cardiolipin-rich inner mitochondrial membrane; interacts with cardiolipin and associated mitochondrial proteins rather than a classical cell-surface receptor46137143

Organism or Origin

Setmelanotide

Synthetic analog of POMC-derived α-MSH peptide928190

SS-31

Fully synthetic Szeto–Schiller tetrapeptide; not encoded in the genome4637

Gene

Setmelanotide

POMC

SS-31

Not assigned in the current dataset.

Summary

Setmelanotide and SS-31 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Setmelanotide is more often discussed in the realm of Metabolic and endocrine, whereas SS-31 is more often associated with the realm of Aging and longevity and Cardiovascular health. They also influence different molecular systems, with Setmelanotide tracking more closely to Melanocortin receptor while SS-31 centers more on Mitochondrial membrane. Both are synthetic in origin and their development context also differs, with Setmelanotide approved while SS-31 is in Clinical phase 2. Setmelanotide takes the form of a cyclic peptide, whereas SS-31 is closer to a linear peptide, while their sequence patterns also diverge, with Setmelanotide showing protein-mimetic sequence features and SS-31 showing cationic amphipathic features.

Related articles

No related articles are linked to these peptides yet.

Sources

31[PDF] 213793Orig1s000 - accessdata.fda.gov, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213793Orig1s000PharmR.pdf
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
92Setmelanotide, https://go.drugbank.com/drugs/DB11700
100Multiple Independent Sub-studies of Setmelanotide in, https://onderzoekmetmensen.nl/en/node/53452/pdf
46Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2 ... - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC11409442/
56Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2 ..., https://pubs.rsc.org/en/content/articlelanding/2024/ra/d4ra05517a
137Mitochondrial protein interaction landscape of SS-31 | PNAS, https://www.pnas.org/doi/10.1073/pnas.2002250117
143SS-31 Peptide: Mitochondrial Repair for Energy and Longevity, https://revolutionhealth.org/blogs/news/peptide-therapy-ss-31